Feb 25, 2021 9:41am
Novo Nordisk s oral Ozempic follow-up, Rybelsus, managed to pull $303 million in 2020 sales. (Novo Nordisk)
Novo Nordisk didn’t let the pandemic scupper the launch of its oral diabetes drug Rybelsus last year. Now, with strong sales on the docket, it’s pledging millions to expand future capacity for the blockbuster-in-waiting.
Novo Nordisk plans to spend 500 million Danish kroner ($82 million) to expand its production facility in Måløv, Denmark. The plant currently turns out Rybelsus, Novo’s oral semaglutide follow-up to its injectable Type 2 diabetes drug Ozempic.
The project, which is expected to wrap in 2022, will lock up future tablet production capacity for Rybelsus. Novo didn’t say what its final capacity would be when the expansion is complete.
Bristol Myers Squibb, freshly armed with an approval for its CAR-T med Breyanzi, is making a major cell therapy manufacturing play. The company laid out plans Tuesday to build a new 244,000-square-foot plant at its campus in Devens, Massachusetts.
Feb 24, 2021 9:00am
Catalent will add Delphi s 17,000-square-foot plasmid DNA facility, pictured here, to its growing cell and gene therapy center of excellence in Gosselies, Belgium. (Delphi Genetics)
Catalent s Belgian manufacturing foothold is widening, as the company moves to acquire yet another cell and gene therapy CDMO in the area.
Catalent locked in a deal to buy 100% of the shares of Delphi Genetics, a plasmid DNA cell and gene therapy CDMO based out of Gosselies, Belgium. The move will help speed the start of commercial plasmid manufacturing at Catalent s facility in Rockville, Maryland, and add to the CDMO s fast-growing hub in Gosselies.
Pfizer, Moderna and Johnson & Johnson execs say they're working all the angles on increasing COVID-19 vaccine production and expect to amp up weekly deliveries by tens of millions by the end of March. Moderna plans to double its output by April, while Pfizer aims to roll out 13 million doses a week next month.
the last time the jobs number came out and showed that unemployment was not only continuing to drop but it had dropped below 8%, when that happened last month, the right got very conspiratorial and decided that that can t be right. the jobs numbers must now be fake. since then, though, the right that was so upset about unemployment going down, they must be really bummed because since then, the economic signs keep pointing in a positive direction. unemployment benefit claims down. worker productivity up. auto sales rising. home builders increasing construction. manufacturing expansion. gains in retail sales. and consumer confidence at the highest level since a year before president obama took office. tomorrow morning at about 8:30 a.m. eastern, we will know if those positive indicators since the last time we got a jobs report mean that we re about to get another good jobs report. if so, that would be very good news for the country.